A new path forward
for ultra-rare disease treatments
Press Releases
CAMBRIDGE, MA – October 19, 2026 – Orphan Therapeutics Accelerator (OTXL), a non-profit biotech focused on completing development and enabling commercial access to shelved rare disease treatments, today announced the appointment of Angela Tom, MS, FNP, as its Head of Medical Affairs.
CAMBRIDGE, MA – October 19, 2026 – Orphan Therapeutics Accelerator (OTXL), a non-profit biotech focused on completing development and enabling commercial access to shelved rare disease treatments, today announced the appointment of Angela Tom, MS, FNP, as its Head of Medical Affairs.
Orphan Therapeutics Accelerator Expands its Network to Extend Development and Access Pathways for Ultra-Rare Disease Therapies